Pure Biologics S.A. (WSE:PUR)
Poland flag Poland · Delayed Price · Currency is PLN
4.912
+0.082 (1.70%)
Jul 16, 2025, 10:41 AM CET

Pure Biologics Revenue

Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
7
Market Cap
19.71M

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 - - -
Dec 31, 2023 - - -
Dec 31, 2022 662.00K 408.00K 160.63%
Dec 31, 2021 254.00K -318.00K -55.59%
Dec 31, 2020 572.00K -1.20M -67.79%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
NEUCA 12.82B
Voxel 556.98M
Synektik Spólka Akcyjna 592.94M
Celon Pharma 215.11M
Ryvu Therapeutics 97.57M
Centrum Medyczne ENEL-MED 762.83M
Selvita 359.79M
EMC Instytut Medyczny 836.81M
Revenue Rankings